Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,282 public trials 1,196 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Trial of ZW25 (Zanidatamab) in Patients With Advanced HER2-expressing Cancers

NCT02892123

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +31 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • USC/Norris Cancer Center Los Angeles, California, United States
  • Hoag Family Cancer Institute Newport Beach, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
View all 17 locations
View Trial Details
Completed

Study of Pemetrexed + Platinum Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With Tyrosine Kinase Inhibitor- (TKI)-Resistant Epidermal Growth Factor Receptor- (EGFR)-Mutated Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-789/KEYNOTE-789)

NCT03515837

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Cedars-Sinai Medical Center ( Site 0070) Los Angeles, California, United States
  • Pacific Cancer Care ( Site 0058) Monterey, California, United States
  • UC Irvine Medical Center/Chao Family Comprehensive Cancer Center ( Site 0092) Orange, California, United States
  • St. Joseph Heritage Healthcare ( Site 0003) Santa Rosa, California, United States
View all 158 locations
View Trial Details
Completed

Supportive Care Mobile Application for Patients With NSCLC

NCT04629300

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Mass General/North Shore Cancer Center Danvers, Massachusetts, United States
  • Dana-Farber Brigham Cancer Center at Milford Regional Medical Center Milford, Massachusetts, United States
View Trial Details
Completed

A Phase 1 Dose-escalation Study of OSI-906 and Erlotinib (Tarceva®)

NCT00739453

Conditions
Advanced Solid Tumors, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
Locations
  • University of Colorado Health Science Center Aurora, Colorado, United States
  • Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Hudson-Webber Cancer Research Center, Karmanos Cancer Institute Detroit, Michigan, United States
  • University of Oxford Department of Medical Oncology Oxford, United Kingdom
View Trial Details
Completed

Study of Continuous OSI-906 Dosing

NCT00514007

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +43 more
Locations
  • Vanderbilt Universtiy Medical Center Nashville, Tennessee, United States
  • The Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
View Trial Details
Completed

Study of Intermittent OSI-906 Dosing

NCT00514306

Conditions
Adnexal Diseases, Advanced Solid Tumors, Breast Diseases, +43 more
Locations
  • MD Anderson Cancer Center Houston, Texas, United States
  • Drug Development Unit, Royal Marsden Hospital Sutton, Surrey, United Kingdom
View Trial Details
Completed

Efficacy Study of Nivolumab Compared to Docetaxel in Subjects Previously Treated With Advanced or Metastatic Non Small Cell Lung Cancer

NCT02613507

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Local Institution - 0051 Beijing, Beijing Municipality, China
  • Local Institution - 0007 Beijing, Beijing Municipality, China
  • Local Institution - 0032 Beijing, Beijing Municipality, China
  • Local Institution - 0026 Beijing, Beijing Municipality, China
View all 33 locations
View Trial Details
Completed

Galinpepimut-S in Combination With Pembrolizumab in Patients With Selected Advanced Cancers

NCT03761914

Conditions
Acute Myelogenous Leukemia, Adnexal Diseases, Breast Diseases, +45 more
Locations
  • St. Joseph Heritage Healthcare Santa Rosa, California, United States
  • Innovative Clinical Research Institute (ICRI) Whittier, California, United States
  • Miami Cancer Institute at Baptist Health, Inc. Miami, Florida, United States
  • Memorial Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States
View Trial Details
Completed

Phase 1 Dose Escalation Study for VIP236 in Patients With Advanced Cancer

NCT05712889

Conditions
Adnexal Diseases, Biliary Tract Diseases, Biliary Tract Neoplasms, +43 more
Locations
  • Honor Health Scottsdale, Arizona, United States
  • NEXT Austin Austin, Texas, United States
  • NEXT Oncology San Antonio San Antonio, Texas, United States
  • Macquarie University Macquarie Park, New South Wales, Australia
View Trial Details

Related conditions